gene

PARKINSON'S DISEASE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARKINSON'S DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7018Connections
0Hypotheses
8Analyses
50Outgoing
50Incoming

Summary

PARKINSON'S DISEASE is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, therapeutic target. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 2353 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolPARKINSON'S DISEASE
Associated DiseasesALS, Aging, Alzheimer, Amyotrophic Lateral Sclerosis, Anxiety
Known Drugs/CompoundsRAPAMYCIN, SEMAGLUTIDE, RESVERATROL, ADUCANUMAB, METFORMIN, LEVODOPA
InteractionsMICROGLIA, P62, ULK1, SQSTM1, NEUROINFLAMMATION, STAT1
KG Connections4474 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| MICROGLIA["MICROGLIA"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| Inflammation["Inflammation"]
        MITOPHAGY_2["MITOPHAGY"] -->|"activates"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    end
    subgraph Pathology["Pathology"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated with"| Parkinson["Parkinson"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated with"| Autophagy["Autophagy"]
        PINK1["PINK1"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
        MITOPHAGY["MITOPHAGY"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
        ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
        ALS["ALS"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
        JUN["JUN"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    end
    subgraph Therapeutic["Therapeutic"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| Parkinson_1["Parkinson"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| Als["Als"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| Proteasome["Proteasome"]
    end
    style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEUROINFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Parkinson fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Parkinson_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Proteasome fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PINK1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOPHAGY fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOPHAGY_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2873)

TargetRelationTypeStr
MICROGLIAactivatesgene1.00
NEUROINFLAMMATIONactivatesgene1.00
Parkinsonassociated_withdisease1.00
Neuroinflammationactivatesdisease1.00
Inflammationactivatesdisease1.00

Incoming (4145)

SourceRelationTypeStr
PINK1associated_withgene1.00
ALZHEIMER'S DISEASEassociated_withgene1.00
ALSassociated_withgene1.00
JUNassociated_withgene1.00
MITOPHAGYactivatesgene1.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (8)

Scientific analyses that reference this entity

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.467

GBA-Synuclein Loop Therapeutics for PD

neurodegeneration | 2026-04-01 | 0 hypotheses

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

neurodegeneration | 2026-04-01 | 0 hypotheses

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found